SCHEMBL6667768

SCHEMBL6667768

CC1(C)CCOc2ccc(C#Cc3cnc(CC(=O)O)nc3)cc21

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 3/20 0.49
CYP26B1 Q9NR63 1/20 0.49
RARB P10826 11/20 0.44
RARG P13631 11/20 0.44
RARA P10276 9/20 0.44
CYP3A4 P08684 3/20 0.42
CRABP2 P29373 1/20 0.42
RXRA P19793 2/20 0.40
HNF4A P41235 1/20 0.40
KMT2A Q03164 1/20 0.39
AKR1B1 P15121 1/20 0.37
SSTR5 P35346 2/20 0.35
BACE1 P56817 1/20 0.35
BACE2 Q9Y5Z0 1/20 0.35
GRM5 P41594 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650596 0.89 CYP26A1 (0.39) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL7651577 0.88 CYP26A1 (0.38) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL6665587 0.87 CYP26A1 (0.38) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL9302760 0.86 RARA (0.46) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL9301731 0.86 CYP26A1 (0.41) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL6664117 0.84 CYP26A1 (0.52) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL6664168 0.84 CYP26A1 (0.46) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL6664727 0.84 CYP26A1 (0.40) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL9266634 0.83 CYP26A1 (0.60) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL8875331 0.83 AKR1B1 (0.40) CYP26A1CYP26B1RARBRARGRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5354752-A A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis ALLERGAN, INC. (US) 1994-10-11 US claimed
EP-0785782-B1 USE OF DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY ALLERGAN INC (US) 2004-09-08 EP disclosed
EP-0785782-A1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY Allergan (US) 1997-07-30 EP disclosed
US-5602130-A ORNITHINE DECARBOXYLASE ENZYME INHIBITOR TREATING SKIN DISORDER, INHIBITING CELL HYPERPROLIFERATION ALLERGAN 1997-02-11 US disclosed
WO-1996011686-A1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY ALLERGAN (US) 1996-04-25 WO disclosed
US-5380877-A Psoriasis treatment; retinoic acid-like activity ALLERGAN, INC. (US) 1995-01-10 US disclosed
US-5354752-A A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis ALLERGAN, INC. (US) 1994-10-11 US disclosed
US-5348972-A In treatment of skin disorders such as acne and psoriasis ALLERGAN, INC. (US) 1994-09-20 US disclosed
US-5234926-A Skin disorders ALLERGAN, INC. (US) 1993-08-10 US disclosed
EP-0284288-B1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID LIKE ACTIVITY ALLERGAN, INC (US) 1992-05-27 EP disclosed
US-5089509-A Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC. (US) 1992-02-18 US disclosed
EP-0284288-A1 Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC (US) 1988-09-28 EP disclosed